Previous studies in tumor cells have shown that MELK can phosphorylate downstream regulatory proteins such as EZH2 and ASK1, thereby altering the activity of major signaling pathways (Li et al., 2019; Seong et al., 2017). This evidence concerns the gene MAP3K5 and neoplasm.